United States · FDA National Drug Code directory
Lubiprostone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60687-816_4dc7a17c-dac7-1755-e063-6294a90aa2e0
- Product NDC
- 60687-816
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- Lubiprostone
- Labeler
- American Health Packaging
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260318
- Source listing expiry
- 20271231
Source-listed ingredients
- LUBIPROSTONE — 8 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 BLISTER PACK in 1 CARTON (60687-816-32) / 1 CAPSULE, GELATIN COATED in 1 BLISTER PACK (60687-816-33) · 60687-816-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →